Pharmacology of Renal Medications Part 2 (Exam 5)

0.0(0)
Studied by 0 people
call kaiCall Kai
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
GameKnowt Play
Card Sorting

1/86

encourage image

There's no tags or description

Looks like no tags are added yet.

87 Terms

1
New cards

What is the action of Antidiuretic Agents?

Hormonal control of fluid preservation in the medullary collecting duct

2
New cards

What is the action of Uricosuric Agents?

Organic anion transport modulation in the proximal tubule

3
New cards

What is the clinical pivot of Antidiuretic & Uricosuric Agents?

Shifting focus from volume excretion to fluid conservation and metabolic waste clearance

4
New cards

What is the physiological role of Antidiuretic Agents?

Synthesized in the hypothalamus, stored in the posterior pituitary, and released in response to high plasma osmolality

5
New cards

What are the antidiuretic agents?

Vasopressin

Desmopressin

6
New cards

What is the MOA of Antidiuretic Agents (Vasopressin & Desmopressin)

Binds to V2 receptors on the basolateral membrane of the collecting duct

Triggers Gs-protein/cAMP cascade to induce exocytosis of Aquaporin-2 channels into the apical membrane

7
New cards

What is the net effect of Antidiuretic Agents?

Massive water reabsorption, concentrating the urine and lowering blood osmolality.

8
New cards

What is Vasopressin (Endogenous ADH)?

Non-selective: Actively stimulates V1 receptors (vasoconstriction) and V2

receptors (antidiuresis).

Short half life (~15-20 minutes)

primarily used in acute resuscitation or shock

9
New cards

What is Desmopressin (DDVAP)?

Synthetic analogue;

highly selective for the V2 receptor

Long-acting (8-12hours) with no significant V1-mediated vasoconstrictive properties

10
New cards

What is the primary use of Vasopressin?

Various conditions

(shock, diabetes insipidus)

11
New cards

What is the primary use of Desmopressin?

Central Diabetes Insipidus (first line)

Nocturnal enuresis

12
New cards

What is the strength of Vasopressin V1a receptor selectivity?

Strong agonist

13
New cards

What is the strength of Desmopressin V1a receptor selectivity

Minimal V1a affinity

14
New cards

What is the V2 receptor selectivity of Vasopressin?

Strong V2 agonist

(Effect: Diuresis)

15
New cards

What is the V2 receptor selectivity of Desmopressin?

Potent & Highly Selective V2 agonist

(Effect: Potent Antidiuresis)

16
New cards

What are the key indications for Vasopressin & Desmopressin?

Central Diabetes Insipidus (V2 effect)

Nocturnal enuresis, and Von Willebrand disease (induces endothelial release of Factor VIII and vWF

17
New cards

What is a major adverse effect of Antidiuretics?

Water intoxication

18
New cards

Excessive water retention leads to

dilutional hyponatremia

19
New cards

What are the symptoms of Antidiuretic toxicity?

Headache, nausea, confusion

Seizures, cerebral edema

20
New cards

What is a Vasopressin specific risk?

HTN

MI

Localized tissue necrosis due to seere V1 vasoconstriction

21
New cards

What is the clinical monitoring for Antidiuretic Toxicity?

Obtain baseline and periodic serum sodium levels

Strictly counsel patient to limit fluid intake for 8 hours following administration to prevent fluid overload

22
New cards

What is the target condition of Uricosuric Agents?

Chronic tophaceous gout stemming from under-excretion of uric acid

23
New cards

What are the prototype Uricosuric Acid Drugs?

Probenecid

Sulfinpyrazone

24
New cards

What is the MOA of Uricosuric Agents?

Competitively inhibits active organic anion transporters (URAT1 and OAT4) in the brush border of the proximal tubule

25
New cards

What is the net effect of Uricosuric agents?

Blocks the reabsorption of filtered uric acid, causing it to stream out in the urine

26
New cards

What is the major adverse effect of Uricosurics?

Nephrolithiasis (Uric Acid Kidney Stones)

High luminal concentrations of uric acid can precipitate out into crystals

27
New cards

What is the paradoxical effect of Uricosurics?

Can acutely trigger or worsen an acute gouty arthritis attack in early in the therapy by mobilizing tissue urate stores

28
New cards

What is the patient education for Uricosurics?

Hydrate = high fluid intake

Avoid aspirin = directly counteract the uricosuric effect of Probenecid

29
New cards

Contraindications of Uricosurics

History of renal impairment or pre-existing uric acid stones

30
New cards

What is the RAAS system?

The fundamental hormonal system controlling systemic blood pressure, fluid volume, and renal hemodynamics

31
New cards

What is the clinical goal of the RAAS system?

Downregulating the vasoconstrictive, aldosterone-releasing and fibrotic pathways of Angiotensin II

32
New cards

What is the scope of the RAAS Modulators?

Moving from traditional first-line blockades (ACEIs, ARBs) to dual-mechanims actions (ARNIs) and cutting-edge exploratory molecules

33
New cards

The counter-regulation of the actions of Ang II by ACE2 occur in at least two ways:

1) It decreases Ang II levels and limits its effects by metabolizing it to Ang(1-7)

2) It increases levels of Ang(1-7), which acts on Mas receptors to oppose Ang II actions

34
New cards

What is the MOA of ACE Inhibitors?

competitively inhibits the angiotensin-converting enzyme (ACE) in pulmonary and vascular endothelium

prevents conversion of inactive Angiotensin I to active Angiotensin II

Inhibits the breakdown of Bradykinin, leading to increased vasodilatory prostaglandins

35
New cards

What is the net renal effect of ACE Inhibitors?

Preferential vasodilation of the efferent arteriole, reducing intraglomerular pressure and halting protein spilling

36
New cards

Adverse effects of ACE Inhibitors

Dry cough & Angioedema

Hyperkalemia

AKI

Teratogenicity

37
New cards

MOA of ARBs

Directly and competitively blocks the Angiotensin II Type 1 (AT1) receptor

Leaves the AT2 receptor unaffected permitting beneficial vasodilatory and antiproliferative signaling

38
New cards

What are the approved ARBs?

Losartan

Valsartan

Irbesartan

Telmisartan

Candesartan & Olmesartan (administered as cilexetil & medoxomil prodrugs)

Azilsartan (Medoxomil prodrug)

39
New cards

What is the clinical advantage of ARBs?

Identical hemodynamic benefit to ACEIs but without the bradykinin accumulation (no dry cough, significantly lower risk of angioedema)

40
New cards

What is the Direct Renin Inhibitor drug?

Aliskiren

41
New cards

What is the MOA of Direct Renin Inhibitors?

Binds directly to the active site of Renin, preventing it from cleaving angiotensinogen

Suppresses Plasma Renin Activity, shutting down the entire downstream synthesis of both angiotensin I and II

42
New cards

What are the clinical limitations of Direct Renin Inhibitors?

Monotherapy for HTN; strictly contraindicated to be combined with ACEIs or ARBs in diabetic patients due to elevated risks of severe hyperkalemia, hypotension, and renal impairment

43
New cards

What are the approved clinical agents for ARNi (Angiotensin Receptor-Neprilysin Inhibitors)?

Sacubitril/Valsartan (Entresto)

44
New cards

What is the MOA of Sacubitril?

A prodrug activated to LBQ657, which inhibits the metalloprotease Neprilysin.

This stops the degradation of endogenous natriuretic peptides (ANP, BNP, bradykinin)

45
New cards

What is the MOA of Valsartan?

Provides concurrent target-organ AT1 receptor blockade

46
New cards

What is the net impact of ARNis?

Combined vasodilation, natriuresis, diuresis, and massive reduction in myocardial remodeling

47
New cards

What is the clinical mainstay of ARNI?

Now considered a preferred frontline therapy for HFrEF (Heart Failure with Reduced Ejection Fraction)

48
New cards

What are the MAS1 Receptor Agonists?

TXA127

AVE0991

49
New cards

What is the concept of MAS1 Receptor?

Stimulating the protective, counter-regulatory RAAS arm that promotes vasodilation, anti-fibrosis, and anti-inflammation

50
New cards

What is TXA127?

An investigational synthetic formulation of Angtiotensin (1-7) designed to bind and activate the MAS1 receptor

51
New cards

What is AVE0091?

A nonpeptide, orally bioavailable MAS1 agonist currently showing highly promising organ protection in preclinical animal models

52
New cards

What is a recombinant Human ACE2

GSK2586881

53
New cards

What is GSK2586881?

Investigational recombinant human ACE2 enzyme

54
New cards

What is the mechanism of GSK2586881?

Directly degrades destructive Angiotensin II while simultaneously generating protective Angiotensin (1-7), pulling the body out of a pro-inflammatory state

55
New cards

What is a Biased AT1 Receptor Agonists?

TRV027

56
New cards

What is TRV027?

An investigational B-arrestin-biased AT1 receptor ligand

57
New cards

What is the mechanism of TRV027?

Uniquely blocks the traditional G-protein signaling pathway responsible for dangerous vasoconstriction, while simultaneously activating the beneficial b-arrestin pathway that promotes cell survival and increases cardiac output.

58
New cards

What is the concept regarding the AT2 Receptor Agonists?

Direct stimulation of the minor, protective Angiotensin II type 2 receptor

59
New cards

What is the status of the AT2 receptor agonists?

Multiple small-molecule agents are undergoing early-phase discovery and preclinical optimization; none are currently approved for clinical use

60
New cards

What are SGLT-2 inhibitors?

Sodium-Glucose Cotransporter 2 inhibitor

61
New cards

What are the SGLT-2 inhibitors (“-gliflozin”) class?

Core agents alter glucose management via the renal pathway

62
New cards

What is the evolution of SGLT-2 Inhibitors?

Began as glycemic control agents; now vital pillars in cardioprotection and nephroprotection

63
New cards

What is the target site of SGLT-2 inhibitors?

proximal convoluted tubule of the nephron

64
New cards

What is the effect of SGLT-2 inhibitors?

Promotes excretion of ~100g of glucose per day

65
New cards

What are the secondary benefits of SGLT-2 inhibitors?

Osmotic diuresis and natriuresis lead to blood pressure reduction and weight loss

66
New cards

What are the insulin-dependent properties of SGLT-2 inhibitors?

lowering glucose does not stimulate insulin secretion, yielding a low risk of hypoglycemia

67
New cards

What is the brand name of Canagliflozin?

Invokana

68
New cards

What are the primary indications for Canagliflozin? (Invokana)

T2D Glycemic Control, MACE reduction, Diabetic Nephropathy

69
New cards

What are the primary indications for Dapagliflozin? (Farxiga)

T2D Glycemic Control, Heart Failure (HFrEF/HFpEF), CKD

70
New cards

What is the brand name for Dapagliflozin?

Farxiga

71
New cards

What is the brand name of Empagliflozin?

Jardiance

72
New cards

What are the primary indications for Empagliflozin?

T2D Glycemic Control, CV Death Risk Reduction, Heart Failure, CKD

73
New cards

What is the brand name for Ertugliflozin?

Steglatro

74
New cards

What are the primary indications for Ertugliflozin?

T2D Glycemic Control

75
New cards

What are the primary indications for Bexagliflozin?

T2D Glycemic Control

76
New cards

What is the brand name for Bexagliflozin?

Brenzavvy

77
New cards

What is the Dual SGLT-1/SGLT-2 inhibitor drug?

Sotagliflozin

78
New cards

What is the brand name for Sotagliflozin?

Inpefa

79
New cards

What is the mechanism of action of Sotagliflozin?

Targets SGLT-2 in the kidneys and SGLT-1 in the GI tract

80
New cards

What is the GI tract impact of Sotagliflozin?

Delays glucose absorption in the gut, minimizing postprandial sugar spikes

81
New cards

What is the primary indication for Sotagliflozin?

Specifically labeled to reduce the risk of CV death and heart failure hospitalizations

82
New cards

What is Sotagliflozin marketed for, but standard management for what?

HF

Glycemic

83
New cards

What are the common risks of Dual SGLT-1/SGLT-2 inhibitors?

Genital mycotic infections (yeast infections)

Urinary Tract Infections (UTIs)

volume depletion/hypotension.

84
New cards

What is the Critical Warning for Dual SGLT-1/SGLT-2 Inhibitors?

Euglycemic Diabetic Ketoacidosis

85
New cards

What is Euglycemic Diabetic Ketoacidosis?

Ketoacidosis can present with perfectly normal or only mildly elevated blood sugars

86
New cards

What are the Canagliflozin specific side effects?

Black box warnings for amputation risk were removed by the FDA, but monitoring lower limb health remains prudent.

87
New cards

What are the renal thresholds for SGLT-1/SGLT-2 inhibitors?

Generally less effective for glucose lowering if eGFR drops below 30 mL/min, though cardiac/renal protective traits persist.